Cargando…

Procoagulant activity of extracellular vesicles in plasma of patients with SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Theresa, L., Whiteside
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175079/ https://www.ncbi.nlm.nih.gov/pubmed/34091416 http://dx.doi.org/10.1016/j.ebiom.2021.103411

Ejemplares similares

Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection
por: Balbi, Carolina, et al.
Publicado: (2021)

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)

The potential of microRNA carried by small extracellular vesicles in cancer plasma to serve as cancer biomarkers
por: Whiteside, Theresa L.
Publicado: (2023)

Head-to-Head Comparison of Tissue Factor-Dependent Procoagulant Potential of Small and Large Extracellular Vesicles in Healthy Subjects and in Patients with SARS-CoV-2 Infection
por: Brambilla, Marta, et al.
Publicado: (2023)

Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation
por: Nielsen, Thøger, et al.
Publicado: (2018)

Procoagulant Activity in Amniotic Fluid Is Associated with Fetal-Derived Extracellular Vesicles
por: Butov, Kirill R., et al.
Publicado: (2022)

Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles
por: Wang, Jiong-Wei, et al.
Publicado: (2017)

Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
por: Ning, Bo, et al.
Publicado: (2021)

Extracellular Vesicle-Based SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma
por: Nielsen, Thøger, et al.
Publicado: (2019)

SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity
por: Cappelletto, Ambra, et al.
Publicado: (2023)

Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection
por: Conzelmann, Carina, et al.
Publicado: (2020)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

Abrupt decreases in infectivity of SARS-CoV-2 in aerosols
por: Löndahl, Jakob, et al.
Publicado: (2022)

The importance of activated TMPRSS2 in the proviral role of small extracellular vesicles in SARS‐CoV‐2 infection
por: Tey, Sze Keong, et al.
Publicado: (2022)

Acute kidney injury in SARS-CoV-2 infected patients
por: Fanelli, Vito, et al.
Publicado: (2020)

Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia
por: Althaus, Karina, et al.
Publicado: (2021)

Consulting the Oracle of SARS-CoV-2 Infection
por: Lemieux, Jacob E, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets
por: Tegegn, Tseday Z., et al.
Publicado: (2016)

Proteomic analysis reveals procoagulant properties of cigarette smoke-induced extracellular vesicles
por: Benedikter, Birke J., et al.
Publicado: (2019)

Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry
por: Holnthoner, Wolfgang, et al.
Publicado: (2017)

The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles
por: Rosas, Marcela, et al.
Publicado: (2020)

Procoagulant Activity of Umbilical Cord-Derived Mesenchymal Stromal Cells’ Extracellular Vesicles (MSC-EVs)
por: Wright, Adrienne, et al.
Publicado: (2023)

ACE2‐enriched extracellular vesicles enhance infectivity of live SARS‐CoV‐2 virus
por: Tey, Sze Keong, et al.
Publicado: (2022)

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
por: Machhi, Jatin, et al.
Publicado: (2021)

Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
por: de Marco, Ario, et al.
Publicado: (2022)

Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
por: Xia, Bingqing, et al.
Publicado: (2023)

Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection
por: Zeng, Yong, et al.
Publicado: (2020)

SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
por: Cardona Maya, Walter D., et al.
Publicado: (2020)

“The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection?
por: Moss, Paul
Publicado: (2020)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
por: Samet, Jonathan M
Publicado: (2020)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

When is the SARS-CoV-2 infection over and what is post-COVID?
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses
por: van der Hoek, Lia
Publicado: (2020)

Alpha variant SARS-CoV-2 infection: How it all starts
por: Domingo, Pere, et al.
Publicado: (2021)

Molecular insights into onset of autoimmunity in SARS‐CoV‐2 infected patients
por: Laxminarayana, Dama
Publicado: (2022)

P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4o0de0pm3kq83r6i7okj5e9rm1